SCHEMBL6891921

SCHEMBL6891921

CCC1=NC(c2cccc(NC(=O)c3ccc(Cl)cn3)c2)(C2CC2)N=C1C

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL931202 0.87 BACE1 (0.59) BACE1
SCHEMBL931182 0.75 BACE1 (0.51) BACE1
SCHEMBL931151 0.73 BACE1 (0.51) BACE1
SCHEMBL932487 0.72 BACE1 (0.60) BACE1
SCHEMBL14482072 0.71 BACE1 (0.77) BACE1
SCHEMBL14482330 0.71 BACE1 (0.77) BACE1
SCHEMBL932477 0.70 BACE1 (0.52) BACE1
SCHEMBL14889556 0.70 BACE1 (0.72) BACE1
SCHEMBL1025970 0.69 BACE1 (0.53) BACE1
SCHEMBL286974 0.69 BACE1 (0.56) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed